@ARTICLE{
author={O'Shaughnessy Joyce,...,Cvetanovic Ana S,...,Stamatovic Ljiljana},
year={2025},
title={Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study},
journal={CLINICAL BREAST CANCER},
volume={25},
number={6},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Geyer Jr Charles E,...,Stamatovic Ljiljana,...,(broj koautora 34)},
year={2025},
title={Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer},
journal={NEW ENGLAND JOURNAL OF MEDICINE},
volume={392},
number={3},
pages={249-257},
document_type={Article},
} 

@ARTICLE{
author={Geyer Jr Charles E,...,Stamatovic Ljiljana,...,(broj koautora 35)},
year={2025},
title={Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer},
journal={NEW ENGLAND JOURNAL OF MEDICINE},
volume={},
number={},
pages={-},
document_type={Article; Early Access},
} 

@ARTICLE{
author={O'Shaughnessy Joyce,...,Cvetanovic Ana S,...,Stamatovic Ljiljana},
year={2021},
title={Original Research Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study},
journal={EUROPEAN JOURNAL OF CANCER},
volume={152},
number={},
pages={223-232},
document_type={Article},
} 

@ARTICLE{
author={O'Shaughnessy Joyce,...,Cvetanovic Ana S,...,Stamatovic Ljiljana},
year={2020},
title={Patient (pt) preference for the pertuzumab-trastuzumab fixed-dose combination for subcutaneous use (PH FDC SC) in HER2-positive early breast cancer (EBC): Primary analysis of the open-label, randomised crossover PHranceSCa study},
journal={ANNALS OF ONCOLOGY},
volume={31},
number={},
pages={S306-S307},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Belkacemi Yazid,...,Tesanovic Dusanka D,...,Popovic Lazar S,...,Kovcin Vladimir N,...,Dzodic Radan R,Markovic Ivan Z,Vasovic Suzana,Stamatovic Ljiljana,Radosavljevic Davorin Z,Radulovic Sinisa S,...,(broj koautora 48)},
year={2020},
title={A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries},
journal={EUROPEAN JOURNAL OF CANCER},
volume={135},
number={},
pages={130-146},
document_type={Review},
} 

@ARTICLE{
author={O'Shaughnessy Joyce,...,Cvetanovic Ana S,...,Stamatovic Ljiljana},
year={2020},
title={Patient (pt) preference and satisfaction with the subcutaneous fixed-dose combination of pertuzumab (P) and trastuzumab (H) in pts with HER2-positive early breast cancer (HER2+eBC): Interim analysis of the open-label, randomised cross-over PHranceSCa study},
journal={ANNALS OF ONCOLOGY},
volume={31},
number={},
pages={S42-S42},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Conte Pier Franco,...,Stamatovic Ljiljana,...,(broj koautora 21)},
year={2020},
title={Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer},
journal={CANCER},
volume={126},
number={13},
pages={3132-3139},
document_type={Article},
} 

@ARTICLE{
author={Todorovic Vladimir,...,Babovic Nada Lj,...,Cetnikovic Bojana,Ceric Timur,...,Dzamic Zoran M,Dzodic Radan R,Eri Zivka,...,Knezevic-Usaj Slavica F,Kovcin Vladimir N,...,Markovic Ivan Z,Markovic Milan,Mijalkovic Nenad,...,Pantelic Aleksandra,Popovic Lazar S,Radosavljevic Davorin Z,...,Radulovic Sinisa S,...,Rosic Ivana,...,Stamatovic Ljiljana,...,Tesanovic Dusanka D,Tomasevic Zorica I,Tomasevic Zoran M,...,Vasovic Suzana,Vicko Ferenc,...,Zaric Bojan,...,(broj koautora 65)},
year={2019},
title={AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan)},
journal={JOURNAL OF BUON},
volume={24},
number={5},
pages={2180-2197},
document_type={Article},
} 

@ARTICLE{
author={Schneeweiss Andreas,...,Stamatovic Ljiljana,...,(broj koautora 20)},
year={2019},
title={Patient-reported outcomes (PROs) from KATHERINE: A phase III study of adjuvant trastuzumab emtansine (T-DM1) versus trastuzumab (H) in patients (pts) with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={37},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Stamatovic Ljiljana,Susnjar Snezana V,Gavrilovic Dusica,Minic Ivana Z,Ursulovic Tamara B,Dzodic Radan R},
year={2018},
title={The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients},
journal={JOURNAL OF BUON},
volume={23},
number={5},
pages={1273-1280},
document_type={Article},
} 

@ARTICLE{
author={Bosnjak Snezana M,Stamatovic Ljiljana,Borroni Maria Elisa,Rizzi Giada,Jordan Karin},
year={2018},
title={Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy},
journal={INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER},
volume={28},
number={6},
pages={1153-1161},
document_type={Article},
} 

@ARTICLE{
author={Krivokuca Ana M,Dragos Vita Setrajcic,Stamatovic Ljiljana,Blatnik Ana,Boljevic Ivana Z,Stegel Vida,Rakobradovic Jelena D,Skerl Petra,Jovandic Stevo,Krajc Mateja,Brankovic-Magic Mirjana V,Novakovic Srdjan},
year={2018},
title={Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin},
journal={FAMILIAL CANCER},
volume={17},
number={2},
pages={179-185},
document_type={Article},
} 

@ARTICLE{
author={Popovic Lazar S,Tomasevic Zorica I,Stamatovic Ljiljana,Markovic Ivan Z,Matovina-Brko Gorana G,Buta Marko N,Golubovic Andrija,Selakovic Vladimir,Trifunovic Jasna D,Mutrezani Zafir,Ivanovic Nebojsa S,Nedovic Jasmina R,Ninkovic Srdjan M,Filipovic Sladjana,Cvetanovic Ana S,Djordjevic Nebojsa P,Karanikolic Aleksandar D,Ivkovic-Kapicl Tatjana V,Vicko Ferenc},
year={2018},
title={Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSE},
journal={JOURNAL OF BUON},
volume={23},
number={2},
pages={522-532},
document_type={Article},
} 

@ARTICLE{
author={Stamatovic Ljiljana,Vasovic Suzana,Trifunovic Jasna D,Boskov Nedeljka,Gajic Z,Parezanovic A,Icevic M,Cirkovic Andja M,Milic Natasa M},
year={2018},
title={Factors influencing time to seeking medical advice and onset of treatment in women who are diagnosed with breast cancer in Serbia},
journal={PSYCHO-ONCOLOGY},
volume={27},
number={2},
pages={576-582},
document_type={Article},
} 

@ARTICLE{
author={Susnjar Snezana V,Stamatovic Ljiljana,Gavrilovic Dusica,Minic Ivana Z,Ursulovic Tamara B},
year={2017},
title={The influence of breast cancer subtypes on response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients},
journal={BREAST},
volume={32},
number={},
pages={S81-S82},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Pljesa Igor,Berisavac Milica,Simic Tatjana P,Pekmezovic Tatjana D,Coric Vesna M,Suvakov Sonja R,Stamatovic Ljiljana,Matic Marija G,Gutic Bojana,Milenkovic Sanja M,Pljesa-Ercegovac Marija S,Savic-Radojevic Ana R},
year={2017},
title={Polymorphic expression of glutathione transferases A1, M1, P1 and T1 in epithelial ovarian cancer: a Serbian case-control study},
journal={JOURNAL OF BUON},
volume={22},
number={1},
pages={72-79},
document_type={Article},
} 

@ARTICLE{
author={Bosnjak Snezana M,Stamatovic Ljiljana,Jordan Karin,Rizzi Giada},
year={2015},
title={Prevention of Chemotherapy-Induced Nausea and Vomiting (Cinv) with Nepa, the First Oral Combination Antiemetic, in Patients with Gynecological Cancers Receiving Platinum-Based Chemotherapy},
journal={INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER},
volume={25},
number={9},
pages={582-583},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Milovic-Kovacevic Marijana M,Susnjar Snezana V,Stamatovic Ljiljana},
year={2015},
title={Changing in Tumor Biology of Triple Negative Breast Cancer Between Primary and Metastatic Lesions},
journal={BREAST},
volume={24},
number={},
pages={S70-S70},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Stamatovic Ljiljana,Mamula-Masic SD,Vukotic Djordje,Kovac Zeljko,Mihailovic Z,Zdravkovic K,Petkovic Danijela,Bagi Teodora,Milic Natasa M},
year={2014},
title={Factors Influencing Time to Seeking Medical Advice and Treatment Onset in Breast Cancer Patients in Serbia},
journal={ANNALS OF ONCOLOGY},
volume={25},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Jassem Jacek,Ozmen Vahit,Bacanu Florin,Drobniene Monika,Eglitis Janis,Lakshmaiah Kuntegowdanahalli C,Kahan Zsuzsanna,Mardiak Jozef,Pienkowski Tadeusz,Semiglazova Tatiana,Stamatovic Ljiljana,Timcheva Constanta,Vasovic Suzana,Vrbanec Damir,Zaborek Piotr},
year={2014},
title={Delays in diagnosis and treatment of breast cancer: a multinational analysis},
journal={EUROPEAN JOURNAL OF PUBLIC HEALTH},
volume={24},
number={5},
pages={761-767},
document_type={Article},
} 

@ARTICLE{
author={Stamatovic Ljiljana,Vasovic Suzana,Milovic-Kovacevic Marijana M,Karaferic Andjela,Lukic Vesna,Pupovac Simonida},
year={2013},
title={TOLERABILITY OF BEVACIZUMAB IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (TNBC) PATIENTS: A SINGLE INSTITUTION EXPERIENCE},
journal={BREAST},
volume={22},
number={},
pages={S50-S51},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Abu Rabi Zaki,Todorovic-Rakovic Natasa,Markicevic Milan A,Stamatovic Ljiljana,Vujasinovic Tijana,Nikolic-Vukosavljevic Dragica},
year={2013},
title={The significance of urokinase system in postmenopausal breast cancer patients},
journal={EUROPEAN JOURNAL OF CANCER},
volume={49},
number={},
pages={S479-S479},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Abu Rabi Zaki,Todorovic-Rakovic Natasa,Markicevic Milan A,Stamatovic Ljiljana,Vujasinovic Tijana,Nikolic-Vukosavljevic Dragica},
year={2013},
title={Change of influence of prognostic markers on metastasis free interval during and after adjuvant tamoxifen therapy in breast cancer patients},
journal={JOURNAL OF BUON},
volume={18},
number={2},
pages={321-327},
document_type={Article},
} 

@ARTICLE{
author={Susnjar Snezana V,Posarac Vladan,Milovanovic Zorka M,Milovic-Kovacevic Marijana M,Stamatovic Ljiljana,Gavrilovic Dusica,Karaferic Andjela},
year={2013},
title={Adjuvant Chemotherapy and Disease Outcome in Triple-Negative Breast Cancer: 3-Year Follow-Up Data},
journal={BREAST},
volume={22},
number={},
pages={S93-S93},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Jassem Jacek,Bacanu Florin,Eglitis Janis,Mardiak Jozef,Pienkowski Tadeusz,Kahan Zsuzsanna,Ozmen Vahit,Drobniene Monika,Vrbanec Damir,Semiglazova Tatyana,Stamatovic Ljiljana,Timcheva Constanta,Vasovic Suzana,Zaborek Piotr},
year={2012},
title={Patient-related factors influencing time between first signs of breast cancer (BC) and appointment for medical visit (AMV): An international survey},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={30},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Markicevic Milan A,Vujasinovic Tijana,Abu Rabi Zaki,Neskovic-Konstantinovic Zora B,Stamatovic Ljiljana,Nikolic-Vukosavljevic Dragica},
year={2012},
title={Postmenopausal Early Breast Cancer Patients - the Relevance of Quantitative ER Values and Follow-up Periods},
journal={EUROPEAN JOURNAL OF CANCER},
volume={48},
number={},
pages={S214-S215},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Susnjar Snezana V,Milovic-Kovacevic Marijana M,Karaferic Andjela,Stamatovic Ljiljana,Gavrilovic Dusica,Jovicevic Ana},
year={2012},
title={Triple-negative Breast Cancer - Which Classical Prognostic Factors Can Help in Identifying Patients with Early Relapse?},
journal={EUROPEAN JOURNAL OF CANCER},
volume={48},
number={},
pages={S132-S132},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Jassem Jacek,Ozmen Vahit,Bacanu Florin,Drobniene Monika,Eglitis Janis,Kahan Zsuzsanna,Lakshmaiah Kuntegowdanahalli C,Mardiak Jozef,Pienkowski Tadeusz,Semiglazova Tatiana,Stamatovic Ljiljana,Timcheva Constanta,Vasovic Suzana,Vrbanec Damir,Zaborek Piotr},
year={2012},
title={Factors influencing time to seeking medical advice and start of treatment in breast cancer (BC) patients - an International survey},
journal={CANCER RESEARCH},
volume={72},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Radenkovic Sandra S,Konjevic Gordana M,Srdic Tatjana V,Stamatovic Ljiljana,Milovic Marijana M,Jurisic Vladimir B},
year={2011},
title={Association of Decreased NK Cell Activity and IFNgamma Expression With pSTAT Dysregulation in Breast Cancer Patients},
journal={EUROPEAN JOURNAL OF CANCER},
volume={47},
number={},
pages={S362-S362},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Konjevic Gordana M,Radenkovic Sandra S,Srdic Tatjana V,Jurisic Vladimir B,Stamatovic Ljiljana,Milovic Marijana M},
year={2011},
title={Association of decreased NK cell activity and IFN gamma expression with pSTAT dysregulation in breast cancer patients},
journal={JOURNAL OF BUON},
volume={16},
number={2},
pages={219-226},
document_type={Article},
} 

@ARTICLE{
author={Susnjar Snezana V,Karaferic Andjela,Milovic-Kovacevic Marijana M,Gavrilovic Dusica,Stamatovic Ljiljana,Milovanovic Zorka M,Jovicevic Ana},
year={2011},
title={Do medullar histology and type of adjuvant chemotherapy influence the short term outcome of triple negative early breast cancer patients?},
journal={BREAST},
volume={20},
number={},
pages={S42-S42},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Milovic-Kovacevic Marijana M,Susnjar Snezana V,Karaferic Andjela,Gavrilovic Dusica,Stamatovic Ljiljana,Milovanovic Zorka M,Jovicevic Ana},
year={2011},
title={Could the lack of expression of steroid receptors and HER2 discriminate a subgroup of triple negative breast cancer patients with poorer prognosis?},
journal={BREAST},
volume={20},
number={},
pages={S40-S41},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Milovic-Kovacevic Marijana M,Stamatovic Ljiljana,Popov Ivan P,Radosevic-Jelic Ljiljana M,Kezic Iva},
year={2010},
title={Platinum - sensitive relapsed epithelial ovarian cancer: Not all the patients benefit from reinduction with carboplatin and paclitaxel},
journal={MEDICAL SCIENCE MONITOR},
volume={16},
number={11},
pages={CR549-CR554},
document_type={Article},
} 

@ARTICLE{
author={Vasovic Suzana,Stamatovic Ljiljana,Tomasevic Zoran M,Karaferic Andjela,Pavlovic L,Karadzic Katarina,Jovanic Irena P},
year={2010},
title={EVALUATION OF PROGNOSTIC VALUE OF HER2 AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) EXPRESSION FOR PREDICTING EARLY FAILURE IN PATIENTS WITH OPERABLE BREAST CANCER},
journal={ANNALS OF ONCOLOGY},
volume={21},
number={},
pages={90-90},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Abu Rabi Zaki,Markicevic Milan A,Vujasinovic Tijana,Lukic Silvana T,Stamatovic Ljiljana,Nikolic-Vukosavljevic Dragica},
year={2010},
title={Early and Late Tamoxifen Resistance in Breast Cancer},
journal={ARCHIVES OF BIOLOGICAL SCIENCES},
volume={62},
number={2},
pages={249-256},
document_type={Article},
} 

@ARTICLE{
author={Milovic Marijana M,Stamatovic Ljiljana,Vasovic Suzana,Karaferic Andjela,Jelic Svetislav B},
year={2009},
title={Platinum-sensitive relapsed epithelial ovarian cancer: how much does the treatment-free interval matter?},
journal={EJC SUPPLEMENTS},
volume={7},
number={2},
pages={456-456},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Vasovic Suzana,Stamatovic Ljiljana,Karaferic Andjela,Minic Ivana Z,Jelic Svetislav B,Gavrilovic Dusica},
year={2008},
title={Pac Regimen In Treatment of Recurrent Ovarian Cancer (Roc)},
journal={ANNALS OF ONCOLOGY},
volume={19},
number={},
pages={215-216},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Stamatovic Ljiljana,Vasovic Suzana,Karaferic Andjela,Tomasevic Zoran M,Jelic Svetislav B},
year={2008},
title={Capecitabine In Cisplatin-Pretreated Metastatic Or Recurrent Squamous Cell Carcinoma of The Cervix: A Possible Therapy Option For Obtaining Clinically Meaningful Outcome?},
journal={ANNALS OF ONCOLOGY},
volume={19},
number={},
pages={214-214},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Susnjar Snezana V,Gavrilovic Dusica,Neskovic-Konstantinovic Zora B,Stamatovic Ljiljana,Ursulovic Tamara B},
year={2007},
title={Relationship of steroid receptor (SR) status and response to fluorouracil, doxorubicine and cyclophosphamide (FAC) primary systemic therapy (PST) in locally advanced breast cancer (LABC) patients},
journal={BREAST},
volume={16},
number={},
pages={S52-S53},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Jovanovic Danica,Radosevic-Jelic Ljiljana M,Tomasevic Zoran M,Vasovic Suzana,Stamatovic Ljiljana,Jelic Svetislav B,Spasic Jelena R},
year={2006},
title={HER-2 status of the primary breast cancer in patients with late disease relapse},
journal={ANNALS OF ONCOLOGY},
volume={17},
number={},
pages={89-89},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Jelic Svetislav B,Nikolic L,Filipovic I,Stamatovic Ljiljana,Radosavljevic Davorin Z},
year={2003},
title={Negative CEA values in metastatic colorectal carcinoma and the likelihood of complete chemotherapy response},
journal={INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS},
volume={18},
number={1},
pages={28-32},
document_type={Article},
} 

@ARTICLE{
author={Jelic Svetislav B,Stamatovic Ljiljana,Vucicevic Slavko S,Petrovic Zeljko M,Kreacic Miroslav,Babovic Nada Lj,Jovanovic Natasa,Mikic Anton A,Gavrilovic Dusica},
year={2002},
title={Use of high-dose cytarabine to enhance cisplatin cytotoxicity - effects on the response and overall survival rates of advanced head and neck cancer patients},
journal={EUROPEAN JOURNAL OF CANCER},
volume={38},
number={11},
pages={1478-1489},
document_type={Article},
} 

@ARTICLE{
author={Stamatovic Ljiljana,Jelic Svetislav B,Susnjar Snezana V,Vasovic Suzana,Nikolic-Tomasevic Zorica I,Neskovic-Konstantinovic Zora B},
year={2002},
title={Salvage capecitabine-leucovorine-vinorelbine combination chemotherapy in both anthracycline and taxane resistant metastatic breast cancer},
journal={EUROPEAN JOURNAL OF CANCER},
volume={38},
number={},
pages={S74-S74},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Jelic Svetislav B,Vasovic Suzana,Stamatovic Ljiljana,Radosavljevic Davorin Z},
year={2002},
title={Values of serum alkaline phosphatase could be useful in rational selection of metastatic breast cancer (MBC) with tumor induced hypercalcemia (TIH) for bisphosphonates treatment},
journal={BONE},
volume={30},
number={3},
pages={53S-53S},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Jelic Svetislav B,Babovic Nada Lj,Stamatovic Ljiljana,Kreacic Miroslav,Matkovic Suzana V,Popov Ivan P},
year={2001},
title={Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures - A single-center study},
journal={MEDICAL ONCOLOGY},
volume={18},
number={3},
pages={189-195},
document_type={Article},
} 

@ARTICLE{
author={Jelic Svetislav B,Babovic Nada Lj,Stamatovic Ljiljana,Vucicevic Slavko S,Pendjer Ivica P,Radulovic Sinisa S},
year={2000},
title={Paclitaxel-cisplatin as first line chemotherapy for undifferentiated carcinoma of the nasopharynx (UCNT): A preliminary report.},
journal={ANNALS OF ONCOLOGY},
volume={11},
number={},
pages={93-93},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Babovic Nada Lj,Jelic Svetislav B,Stamatovic Ljiljana},
year={2000},
title={Cisplatin dose intensity in poor risk germ cell tumors.},
journal={ANNALS OF ONCOLOGY},
volume={11},
number={},
pages={77-77},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Radosavljevic Davorin Z,Jelic Svetislav B,Babovic Nada Lj,Popov Ivan P,Kreacic Miroslav,Stamatovic Ljiljana,Nikolic-Tomasevic Zorica I,Kezic Iva},
year={2000},
title={Addition of medroxyprogesterone-acetate (MPA) to interferon-alpha (IFN) vinblastine (VLB) combination in advanced renal-cell carcinoma (RCC) - is there any impact on quality of life (QoL)?},
journal={ANNALS OF ONCOLOGY},
volume={11},
number={},
pages={75-75},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Stamatovic Ljiljana,Jelic Svetislav B,Susnjar Snezana V,Vasovic Suzana},
year={2000},
title={Docetaxel-mitomycin-vinblastine combination chemotherapy in patients with anthracycline-resistant advanced breast cancer (ABC): An interim report.},
journal={ANNALS OF ONCOLOGY},
volume={11},
number={},
pages={27-27},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Susnjar Snezana V,Vasovic Suzana,Neskovic-Konstantinovic Zora B,Stamatovic Ljiljana,Lukic Vesna,Colakovic Slobodanka,Mitrovic LB,Jelic Svetislav B,Radulovic Sinisa S},
year={1999},
title={Mitoxantrone, 5-fluorouracil and low-dose leucovorin in doxorubicin-resistant advanced breast cancer patients: A phase II study},
journal={TUMORI},
volume={85},
number={6},
pages={478-482},
document_type={Article},
} 

